Moderna, Pfizer’s COVID Vaccine Storage Requirements Raise Questions


The COVID-19 vaccine candidates being developed by Moderna Inc. and BioNTech and Pfizer Inc. will require stringent standards for refrigeration, and that may hamper how they are distributed to the hundreds of millions of Americans expecting to receive them.

Shares of Moderna MRNA, -3.50% were down 3.6% in trading on Thursday, following a rally on Wednesday after the company’s disclosure that people older than 55 years old who participated in the Phase 1 trial had demonstrated neutralizing antibody titers. Pfizer’s PFE, -0.49% stock was down 0.5% in Thursday trading, while BioNTech BNTX, -3.40% tumbled 4.3%.

Executives from Moderna and Pfizer on Wednesday separately told the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practice on Wednesday that mRNA-1273, which is Moderna’s coronavirus vaccine candidate, requires a storage temperature of negative 4 degrees Fahrenheit. BioNTech and Pfizer’s candidates, BN1162b2 and BNT162b2, need to be stored in negative 94 degrees Fahrenheit.

Heat St

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s